https://www.selleckchem.com/pr....oducts/Novobiocin-so
6046), postoperative complications (38% versus 20%, P=0.183), or mortality (0.04% versus 0.04%, P=1.. Epidural analgesia and TAWC may have comparable perioperative outcomes in patients undergoing pancreatic surgery. Further randomized studies with a larger cohort of patients are warranted to identify the best postoperative analgesic method in patients undergoing pancreatic resection. Epidural analgesia and TAWC may have comparable perioperative outcomes in patients undergoing pancreatic surgery. Further randomized